POST Online Media Lite Edition


EyeGate Pharma appoints Ryan R. Brenneman as CFO

Staff writer |
Waltham, Mass., USA - April 29, 2016, Waltham, Mass., USA - EyeGate Pharmaceuticals, a specialty pharmaceutical company, announced the appointment of Ryan R. Brenneman as its chief financial officer.

Article continues below

Mr. Brenneman has 18 years of experience. Prior to joining EyeGate, he served as Senior Vice President and Chief Accounting Officer at CYS Investments. Previously, he was Managing Director and Chief Accounting Officer at First Marblehead Corporation.

Mr. Brenneman spent over four years at Freddie Mac, a real estate mortgage and securities asset manager, where he served as Controller – Multifamily Accounting and Controller – Investments and Capital Markets Accounting.

Mr. Brenneman has also held senior-level finance positions at organizations including Booz Allen Hamilton, Protiviti, InterSystems Corporation and NerveWire and has served as an Independent CFO Consultant to several companies in the Boston area.

Mr. Brenneman holds a J.D. from Georgetown University, a Masters in Accountancy from George Washington University, an M.S. in Public Policy and Administration from the London School of Economics and an A.B. (cum laude) in Government from Bowdoin College.

LATEST 5 MOVES FROM Massachusetts 

What to read next

EyeGate Pharmaceuticals appoints three executives
Tim Ryan to re-join JPMorgan Chase as global head of regulatory strategy and policy
CentralNic appoints Sarah Ryan as development director